Anders Møller
@andersmdr
MD, PhD, Specialist registrar in anaesthesia and intensive care | interests: transfusion, coagulation and haemodynamics | principal investigator of the TV trial
ID: 2874957459
http://www.clinicaltrials.gov/ct2/show/NCT024651 13-11-2014 12:05:40
166 Tweet
207 Takipçi
364 Takip Edilen
Danske intensivafdelinger var godt med, da coronabølgen skyllede ind over landegrænserne i foråret, fortæller intensivlæge nicolai haase på Rigshospitalet. Uhyre omfattende dansk undersøgelse af covid-patienter er offentliggjort #sundpol #dksund #COVID19 rigshospitalet.dk/presse-og-nyt/…
Is less more when it comes to red blood cell transfusion? Anders Møller will discuss liberal vs. restrictive transfusion in his NATA lecture. Don't miss the session HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE (April 12, 11:30 CEST & April 19:30 CEST) rebrand.ly/fax3cpo
#Statistics thought of the day from Andy Field methodspace.com/top-5-statisti… @vandy_biostat Vanderbilt University Data Science Institute @EdgeforScholars #bbrcourse
@AndersPerner CRIC The George Institute for Global Health India Congratulations, Anders, Marie, and co. Your effort and scientific collaboration are truly exemplary. My take: I would take the 12 mg if it were me with severe COVID. I don't see indications in the results supporting 6 mg. Looking forward to the bayesian and long-term follow-up
Monday - 1930 GMT. The RePHILL results will be presented live by Jon Bishop Caroline Leech and myself before simultaneous publication. Anyone interested in trauma resuscitation should join the Critical Care Reviews livestream ella